These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21982511)

  • 21. Long-term prevention of chronic allograft rejection by regulatory T-cell immunotherapy involves host Foxp3-expressing T cells.
    Pasquet L; Douet JY; Sparwasser T; Romagnoli P; van Meerwijk JP
    Blood; 2013 May; 121(21):4303-10. PubMed ID: 23580663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allopeptides and the alloimmune response.
    Bharat A; Mohanakumar T
    Cell Immunol; 2007 Jul; 248(1):31-43. PubMed ID: 18023633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts.
    Choi JY; Eskandari SK; Cai S; Sulkaj I; Assaker JP; Allos H; AlHaddad J; Muhsin SA; Alhussain E; Mansouri A; Yeung MY; Seelen MAJ; Kim HJ; Cantor H; Azzi JR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6042-6046. PubMed ID: 32111690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile.
    Le Texier L; Thebault P; Lavault A; Usal C; Merieau E; Quillard T; Charreau B; Soulillou JP; Cuturi MC; Brouard S; Chiffoleau E
    Am J Transplant; 2011 Mar; 11(3):429-38. PubMed ID: 21114655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.
    Ochando JC; Yopp AC; Yang Y; Garin A; Li Y; Boros P; Llodra J; Ding Y; Lira SA; Krieger NR; Bromberg JS
    J Immunol; 2005 Jun; 174(11):6993-7005. PubMed ID: 15905542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines affecting CD4
    Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
    Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T helper subsets & regulatory T cells: rethinking the paradigm in the clinical context of solid organ transplantation.
    Askar M
    Int J Immunogenet; 2014 Jun; 41(3):185-94. PubMed ID: 24495112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.
    Miyairi S; Hirai T; Ishii R; Okumi M; Nunoda S; Yamazaki K; Ishii Y; Tanabe K
    Eur J Immunol; 2017 Apr; 47(4):734-742. PubMed ID: 28127757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Immunological Basis of Liver Allograft Rejection.
    Ronca V; Wootton G; Milani C; Cain O
    Front Immunol; 2020; 11():2155. PubMed ID: 32983177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.
    Hou J; Zhang Q; Fujino M; Cai S; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Xu J; Zou H; Ding Q; Li XK
    J Heart Lung Transplant; 2015 Feb; 34(2):254-63. PubMed ID: 25455753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term control of alloreactive B cell responses by the suppression of T cell help.
    Li Y; Ma L; Yin D; Shen J; Chong AS
    J Immunol; 2008 May; 180(9):6077-84. PubMed ID: 18424729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of Th17 cells on transplant rejection and the induction of tolerance.
    Heidt S; Segundo DS; Chadha R; Wood KJ
    Curr Opin Organ Transplant; 2010 Aug; 15(4):456-61. PubMed ID: 20616728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming Chronic Rejection-Can it B?
    Kwun J; Knechtle SJ
    Transplantation; 2009 Oct; 88(8):955-61. PubMed ID: 19855237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tregs-based immunotherapy: an efficient way to fully inhibit acute and chronic rejection].
    Joffre O; Santolaria T; van Meerwijk JP
    Med Sci (Paris); 2008; 24(8-9):689-91. PubMed ID: 18789210
    [No Abstract]   [Full Text] [Related]  

  • 37. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.
    Noorchashm H; Reed AJ; Rostami SY; Mozaffari R; Zekavat G; Koeberlein B; Caton AJ; Naji A
    J Immunol; 2006 Dec; 177(11):7715-22. PubMed ID: 17114442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells in transplantation.
    Wood KJ
    Transplant Proc; 2011; 43(6):2135-6. PubMed ID: 21839214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the direct and indirect pathways of allorecognition in chronic allograft failure.
    Baker RJ; Hernandez-Fuentes MP; Brookes PA; Chaudhry AN; Lechler R
    Transplant Proc; 2001; 33(1-2):449. PubMed ID: 11266904
    [No Abstract]   [Full Text] [Related]  

  • 40. The yin and yang of B cells in graft rejection and tolerance.
    Zarkhin V; Chalasani G; Sarwal MM
    Transplant Rev (Orlando); 2010 Apr; 24(2):67-78. PubMed ID: 20149626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.